B of A Securities Maintains Buy on Guardant Health, Raises Price Target to $190
Benzinga Newsdesk 3 months ago
Analyst RatingsNewsPrice Target
B of A Securities analyst Michael Ryskin maintains Guardant Health (NASDAQ:GH) with a Buy and raises the price target from $135 to $190.
B of A Securities analyst Michael Ryskin maintains Guardant Health (NASDAQ:GH) with a Buy and raises the price target from $135 to $190.